Pfm Health Sciences, LP Halozyme Therapeutics, Inc. Transaction History

Pfm Health Sciences, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $15.4 Million - $17.7 Million	-597,545 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$16.25 - $26.81 $344,191 - $567,862	-21,181 Reduced 3.42%	597,545 $16 Million
Q1 2020 May 15, 2020	BUY	$13.9 - $21.83 $350,919 - $551,120	25,246 Added 4.25%	618,726 $11.1 Million
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $8.86 Million - $11.6 Million	593,480 New	593,480 $10.5 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.